Luvometinib

2739690-43-6

12352005

MEK

Reference compound

MAPK/ERK Pathway

Cancer-Kinase/protease

Cancer

https://www.medchemexpress.com/luvometinib.html

99.94

DMSO : 100 mg/mL (ultrasonic)

O=C1C(F)=C(C2=C(N1C)C(C3=CC(NS(=O)(C4CC4)=O)=CC=C3)=NN(C5CC5)C2=O)NC6=CC=C(C=C6F)I

C26H22F2IN5O4S

665.45

[1]International Nonproprietary Names for Pharmaceutical Substances (INN) . WHO Drug Information, Vol. 38, No. 2, 2024.

Room Temperature

-20°C, 3 years; 4°C, 2 years (Powder)

Reference compound1

Phase 3